May 13, 2026 | CFO-Services, H&P News
Patrick Schacher, CFO-Partner, had the opportunity to talk to Dr. Stephen Helliwell at our booth at Swiss Biotech Day about the latest challenges for the life science industry and how to tackle them with part-time or fractional models of CFO and CSO experts. Swiss...
May 8, 2026 | H&P News, M&A
Hoffmann & Partner, the Basel-based M&A advisory firm specialising in healthcare, acted as the exclusive financial advisor to the shareholders of PharmaX Solutions.BioPhorum, a portfolio company of Five Arrows, has acquired PharmaX Solutions, a consultancy...
Apr 6, 2026 | CFO-Services, Corporate Finance, H&P News, M&A
The latest webinar organised by BaseLaunch provided practical insights into the key financial priorities for biotech start-ups. Our experts in M&A and CFO services, Dr Urs Breitenstein, Simon Marti and Georg Estermann, presented 43 practical and actionable...
Nov 5, 2025 | H&P News, M&A
The CDMO landscape is evolving rapidly, with certain segments — such as biologics, cell and gene therapies and advanced aseptic manufacturing — experiencing strong growth, while more traditional small-molecule and generics-focused areas face increasing margin pressure...
Sep 17, 2025 | H&P News, M&A
Basel / Berlin / Rostock, September 2025 – Hoffmann & Partner is pleased to announce that it has advised the shareholders of Nostos Genomics GmbH (“Nostos”) as M&A advisors in the successful acquisition by Limbus Medical Technologies GmbH (“Limbus”). Two...
